Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1980 Feb;43(2):102–105. doi: 10.1136/jnnp.43.2.102

Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.

L Stendahl-Brodin, H Link
PMCID: PMC490482  PMID: 7359146

Abstract

The prognosis in multiple sclerosis (MS) is related to the presence of an abnorma humoral immune response within the central nervous system: 14/17 MS patients (82%) without oligoclonal CSF IgG displayed no or slight disability after a mean duration of MS of 17 years, while 53% of 88 patients with oligoclonal CSF IgG had a benign course after a mean duration of 13 years (p less than 0.05). A benign course also was more often accompanied by a normal CSF IgG index. MS patients without oligoclonal CSF IgG had elevated CSF/serum ratios of albumin in 6%, and of the complement factors C3 in 0% and C4 in 6%, as against 20%, 27% and 37%, respectively, in MS patients with oligoclonal CSF IgG.

Full text

PDF
102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Johnson K. P., Arrigo S. C., Nelson B. J., Ginsberg A. Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. A simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands. Neurology. 1977 Mar;27(3):273–277. doi: 10.1212/wnl.27.3.273. [DOI] [PubMed] [Google Scholar]
  2. Laterre E. C., Callewaert A., Heremans J. F., Sfaello Z. Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology. 1970 Oct;20(10):982–990. doi: 10.1212/wnl.20.10.982. [DOI] [PubMed] [Google Scholar]
  3. Laurenzi M. A., Link H. Comparison between agarose gel electrophoresis and isoelectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders. Acta Neurol Scand. 1978 Sep;58(3):148–156. doi: 10.1111/j.1600-0404.1978.tb02874.x. [DOI] [PubMed] [Google Scholar]
  4. Link H. Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin Chim Acta. 1973 Jul 27;46(4):383–390. doi: 10.1016/0009-8981(73)90251-9. [DOI] [PubMed] [Google Scholar]
  5. Link H., Laurenzi M. A. Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation. Ann Neurol. 1979 Aug;6(2):107–110. doi: 10.1002/ana.410060205. [DOI] [PubMed] [Google Scholar]
  6. Link H., Müller R. Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol. 1971 Oct;25(4):326–344. doi: 10.1001/archneur.1971.00490040052007. [DOI] [PubMed] [Google Scholar]
  7. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest. 1977 Sep;37(5):397–401. doi: 10.1080/00365517709091498. [DOI] [PubMed] [Google Scholar]
  8. Link H., Zettervall O., Blennow G. Individual cerebrospinal fluid (CSF) proteins in the evaluation of increased CSF total protein. Z Neurol. 1972;203(2):119–132. doi: 10.1007/BF00316040. [DOI] [PubMed] [Google Scholar]
  9. Link H., Zettervall O. Multiple sclerosis: disturbed kappa: lambda chain ratio of immunoglobulin G in cerebrospinal fluid. Clin Exp Immunol. 1970 Mar;6(3):435–438. [PMC free article] [PubMed] [Google Scholar]
  10. Olsson J. E., Link H. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions. Arch Neurol. 1973 Jun;28(6):392–399. doi: 10.1001/archneur.1973.00490240052009. [DOI] [PubMed] [Google Scholar]
  11. Olsson J. E., Link H., Müller R. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: disability, duration and age of onset. J Neurol Sci. 1976 Feb;27(2):233–245. doi: 10.1016/0022-510x(76)90064-2. [DOI] [PubMed] [Google Scholar]
  12. Sandberg-Wollheim M., Zettervall O., Müller R. In vitro synthesis of IgG by cells from the cerebrospinal fluid in a patient with multiple sclerosis. Clin Exp Immunol. 1969 Apr;4(4):401–405. [PMC free article] [PubMed] [Google Scholar]
  13. Tibbling G., Link H., Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977 Sep;37(5):385–390. doi: 10.1080/00365517709091496. [DOI] [PubMed] [Google Scholar]
  14. Tourtellotte W. W., Ma B. I. Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 1978 Sep;28(9 Pt 2):76–83. doi: 10.1212/wnl.28.9_part_2.76. [DOI] [PubMed] [Google Scholar]
  15. Vandvik B., Natvig J. B., Wiger D. IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol. 1976;5(4):427–436. doi: 10.1111/j.1365-3083.1976.tb00297.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES